NDC Package 68040-714-08 Sernivo

Betamethasone Dipropionate Spray Topical - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
68040-714-08
Package Description:
1 BOTTLE, SPRAY in 1 CARTON / 10 g in 1 BOTTLE, SPRAY
Product Code:
Proprietary Name:
Sernivo
Non-Proprietary Name:
Betamethasone Dipropionate
Substance Name:
Betamethasone Dipropionate
Usage Information:
This medication is used to treat a type of skin condition (plaque psoriasis). Betamethasone reduces the swelling, itching, and redness that may occur with plaque psoriasis. This medication is a strong corticosteroid.
11-Digit NDC Billing Format:
68040071408
NDC to RxNorm Crosswalk:
  • RxCUI: 1738536 - betamethasone 0.05 % Topical Spray
  • RxCUI: 1738536 - betamethasone 0.5 MG/ML Topical Spray
  • RxCUI: 1738536 - betamethasone (as dipropionate) 0.05 % Topical Spray
  • RxCUI: 1738536 - betamethasone dipropionate 0.064 % Topical Spray
  • RxCUI: 1738541 - Sernivo 0.05 % Topical Spray
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Primus Pharmaceuticals, Inc.
    Dosage Form:
    Spray - A liquid minutely divided as by a jet of air or steam.
    Administration Route(s):
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
  • Sample Package:
    No
    FDA Application Number:
    NDA208079
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    06-28-2021
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    68040-714-281 BOTTLE, SPRAY in 1 CARTON / 120 g in 1 BOTTLE, SPRAY

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 68040-714-08?

    The NDC Packaged Code 68040-714-08 is assigned to a package of 1 bottle, spray in 1 carton / 10 g in 1 bottle, spray of Sernivo, a human prescription drug labeled by Primus Pharmaceuticals, Inc.. The product's dosage form is spray and is administered via topical form.

    Is NDC 68040-714 included in the NDC Directory?

    Yes, Sernivo with product code 68040-714 is active and included in the NDC Directory. The product was first marketed by Primus Pharmaceuticals, Inc. on June 28, 2021 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 68040-714-08?

    The 11-digit format is 68040071408. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-268040-714-085-4-268040-0714-08